Name: Fmoc-Ala-Ala-Asn-PAB-PNP
Brand: BOC Sciences
Rating: 5 (1 reviews)

Size

Price

Stock

Quantity

$--

In stock

Synonyms

Fmoc-Ala-Ala-Asn-PABC-PNP; (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-(((S)-4-amino-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1,4-dioxobutan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)carbamate

IUPAC Name

[4-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate

Canonical SMILES

CC(C(=O)NC(CC(=O)N)C(=O)NC1=CC=C(C=C1)COC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)C(C)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35

InChI

InChI=1S/C39H38N6O11/c1-22(41-35(47)23(2)42-38(50)54-21-32-30-9-5-3-7-28(30)29-8-4-6-10-31(29)32)36(48)44-33(19-34(40)46)37(49)43-25-13-11-24(12-14-25)20-55-39(51)56-27-17-15-26(16-18-27)45(52)53/h3-18,22-23,32-33H,19-21H2,1-2H3,(H2,40,46)(H,41,47)(H,42,50)(H,43,49)(H,44,48)/t22-,23-,33-/m0/s1

InChIKey

KVDVZTLIGXDKKC-BHWLZUDQSA-N

Density

1.382±0.06 g/cm3

Solubility

Soluble in DMSO

Appearance

Solid

Shipping

Room temperature, or blue ice upon request.

Storage

Store at -20 °C, keep in dry and avoid sunlight

Boiling Point

1117.7±65.0 °C at 760 mmHg

Fmoc-Ala-Ala-Asn-PAB-PNP, a synthetic compound, plays a pivotal role in modern biomedical research and drug development due to its highly discriminating inhibitory properties. This molecular entity is engineered to interact specifically with target proteins, thereby modulating their function in pathways relevant to disease processes. Particularly in the realm of oncology, Fmoc-Ala-Ala-Asn-PAB-PNP has gained attention for its ability to selectively inhibit enzymes and pathways that are dysregulated in cancer. Its specific activity profile provides an advantage in minimizing off-target effects, thereby enhancing the therapeutic window. The compound’s stability and the efficiency with which it can be incorporated into larger molecular frameworks make it an ideal candidate for developing targeted therapies aimed at malignant tissues.

In drug discovery, the strategic incorporation of Fmoc (Fluorenylmethyloxycarbonyl) group enhances the compound’s stability, allowing it to withstand complex biological environments without premature degradation. This stability is critical in maintaining the integrity of the drug as it navigates through the biological pathways to reach its target location. Additionally, the Ala-Ala-Asn peptide sequence enhances the molecule’s ability to penetrate cells, ensuring that the inhibitory action of Fmoc-Ala-Ala-Asn-PAB-PNP is effectively delivered where it’s most needed. In cancer research, this precision is crucial, as it can lead to significant improvements in targeting tumor cells while sparing normal, healthy cells from unnecessary chemical exposure.

Furthermore, the PAB (p-Aminobenzyl) spacer in the molecule is instrumental in facilitating controlled drug release. In the context of cancer therapeutics, this characteristic is particularly beneficial as it allows the active drug to be released at specific sites within the body, directly into tumor cells or the surrounding microenvironment. This targeted release mechanism not only improves the efficacy of the drug but also reduces collateral damage to non-cancerous cells, thereby diminishing the side effects commonly associated with conventional chemotherapy. Incorporating such a feature demonstrates the advancement in design strategies employed in current drug discovery programs, emphasizing precision medicine.

The potential of Fmoc-Ala-Ala-Asn-PAB-PNP extends beyond oncology. Its structural components allow it to be adapted for use against a variety of pathogenic targets, opening avenues in infectious diseases and autoimmune disorders. By altering the peptide framework, various derivatives can be synthesized to interact with different proteins, offering a versatile platform for the development of novel therapeutics. This adaptability is crucial in drug discovery, where the ability to modulate chemical structures to target new and emerging threats rapidly is paramount. In essence, Fmoc-Ala-Ala-Asn-PAB-PNP serves as a scaffolding molecule that can be customized to meet the demands of numerous therapeutic areas.